Patents Assigned to LUODA PHARMA LIMITED
  • Methods of treating microbial infections, including mastitis
    Patent number: 11491105
    Abstract: The invention includes methods and compositions for treating mastitis in a subject. The method includes the step of administering, by intramammary delivery, a therapeutically effective amount of a polyether ionophore, or a therapeutically acceptable salt thereof, to the mammary gland of the subject.
    Type: Grant
    Filed: February 10, 2014
    Date of Patent: November 8, 2022
    Assignee: LUODA PHARMA LIMITED
    Inventors: Stephen Page, Sanjay Garg
  • Liquid formulation
    Patent number: 11357855
    Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.
    Type: Grant
    Filed: August 16, 2019
    Date of Patent: June 14, 2022
    Assignee: LUODA PHARMA LIMITED
    Inventors: Nicholas Bova, Stephen Page, Giuseppe Pippia
  • Methods and compositions for treating gastric ulcers
    Patent number: 11318123
    Abstract: A method of treating and/or preventing gastric ulcers, said method comprising administering by injection a therapeutically effective amount of a composition comprising: c) a first agent selected from the group consisting of: a medium chain triglyceride and a long chain triglyceride; and d) a second agent comprising a proton pump inhibitor or pharmaceutically or veterinary acceptable salt, wherein the composition is adapted for sustained release of a therapeutically effective amount of the proton pump inhibitor to a subject in need thereof.
    Type: Grant
    Filed: December 8, 2016
    Date of Patent: May 3, 2022
    Assignee: LUODA PHARMA LIMITED
    Inventors: Nicholas Bova, Sanjay Garg, Stephen Page
  • Liquid formulation
    Patent number: 10413610
    Abstract: The invention relates to a liquid formulation comprising propylene glycol and an effective amount of an inodilator, an angiotensin converting enzyme inhibitor, or a combination of an inodilator and an angiotensin converting enzyme inhibitor and to use of the formulation for treating cardiac disease and/or hypertension.
    Type: Grant
    Filed: October 5, 2017
    Date of Patent: September 17, 2019
    Assignee: LUODA PHARMA LIMITED
    Inventors: Nicholas Bova, Stephen Page, Giuseppe Pippia